Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,348,060
-$102,668 QoQ
Shares Held
265,088
+21.1% QoQ
Ownership
0.912%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. ENTA ranks #198 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,348,060 | 265,088 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,450,728 | 218,816 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,992,202 | 166,433 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $877,979 | 116,135 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $719,862 | 130,410 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $712,200 | 123,861 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,658,977 | 160,133 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,099,997 | 84,811 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,583,446 | 90,690 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,756,291 | 186,641 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,260,823 | 291,927 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $5,116,076 | 239,069 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $9,304,839 | 230,090 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $10,952,947 | 235,446 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $9,056,242 | 174,595 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $6,540,087 | 138,356 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $7,153,660 | 100,501 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,947,501 | 119,651 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,813,479 | 102,332 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $6,312,397 | 143,431 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,704,017 | 135,929 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,795,529 | 161,414 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $15,424,471 | 336,926 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,263,786 | 363,748 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $19,019,893 | 369,821 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||